Dr Michelle Critchley

Manager, Delivery and Sensing Development

NanoVic

Suite 201, Level 2, 3 Chester Street
Oakleigh
Victoria
3166
Australia

PH: 61 (3) 95673703
Fax: 61 (3) 95681214
Email: [email protected]
Click here to visit Web Site

Background

Dr Michelle Critchley has joined Nanotechnology Victoria on a full-time basis from January 1st 2008. Michelle commenced with NanoVic in 2004 on secondment from CSIRO to work on bio-nano related projects with Dr Bob Irving and the Sensing & Delivery team. Since then, Michelle has been an important contributor to NanoVic’s capabilities, particularly through her understanding of the impact of nanostructured materials on biological systems. Her research at CSIRO spanned a variety of client industries including biotechnology, aerospace, food safety, Legionella control and biosensor development.

At NanoVic, Michelle has led several major projects including the Transdermal Delivery Project on novel drug and vaccine delivery mechanisms with the Victorian College of Pharmacy, and the Nanoparticle Diagnostics Project with RMIT University. She has also supported the nanostructured materials team in the development of anti-bacterial surfaces and tools, where her environmental and public health risk assessment expertise was invaluable.

Michelle was awarded the ASCEPT prize in 1997 and the Australasian Corrosion Association AMAC Award in 2000. In June 2007, Michelle was awarded one of the prestigious Australian Academy grants to undertake international collaborative research. She used this to collaborate with the USA Centre for Management, Protection and Utilization of Water Resources at the Technical University of Tennessee in August 2007. Michelle was also an author of a Special Report: Nanotechnology: the Next Wave of Commercial Development for Health and Medical Devices - The Australian Story in Nanomedicine 2(2) in April 2007, with Dr Bob Irving and Dr Jeanette Pritchard.

Michelle is active in developing new technologies, particularly around transdermal delivery of nanoparticle medicines. Together with Dr Bob Irving of NanoVic, Professor Colin Pouton and Dr Paul White of Victorian College of Pharmacy, Michelle is an inventor on the patent application (PCT: WO 2007/012114 lodged July 2006) for the transdermal delivery MicroArray Device. Further developments will be protected and announced in the near future.

Over the last year, Michelle has been completing a Masters in Intellectual Property Law, and is already playing a role in NanoVic’s IP management. Michelle also contributes to NanoVic’s educational activities and to initiatives with NanoSafe Australia. Michelle is a participant in the 2007 DEST Scientists in Schools Program, promoting science in Victorian primary schools.

Michelle has taken leave from CSIRO, and joins NanoVic full-time as Manager Operations for the Interstitial NS drug delivery venture. In this capacity, she has taken responsibility for development of the Interstitial Business Plan and leading the commercialization activities for this portfolio.

Major Qualifications

Michelle was awarded the ASCEPT prize in 1997 and the Australasian Corrosion Association AMAC Award in 2000. In addition to her project activities, Michelle contributes to educational and public awareness initiatives for biotechnology and nanotechnology. Michelle has an undergraduate degree in Environmental Health from the Flinders University of South Australia, and a PhD in Environmental Microbiology, obtained from the same institution.